About: Elena Seminari

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Elena Seminari Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	forskare (sv) ikertzailea (eu) researcher (en) 연구원 (ko) 研究者 (ja) araştırmacı (tr) wetenschapper (nl) дослідниця (uk) эрдэмтэн (mn) изилдөөчү (ky) 研究者 (zh) հետազոտող (hy) hulumtuese (sq)
rdfs:label	Elena Seminari (en) Elena Seminari (es) Elena Seminari (it) Elena Seminari (nl) Elena Seminari (sl) Elena Seminari (ast)
skos:prefLabel	Elena Seminari (en) Elena Seminari (es) Elena Seminari (it) Elena Seminari (nl) Elena Seminari (sl) Elena Seminari (ast)
name	Elena Seminari (en) Elena Seminari (es) Elena Seminari (it) Elena Seminari (nl) Elena Seminari (sl) Elena Seminari (ast)
Scopus author ID	wds:Q56384025-0DB9FF2C-3B59-4258-8B84-E002B17BCB5A
Scopus author ID	55882455100
given name	wds:Q56384025-B70354CC-33EE-4DD8-B6BF-92A19B56BDE4
given name	Elena
instance of	wds:Q56384025-102B3064-5E09-42A0-97D8-79C321AB6F39
instance of	Homo sapiens
occupation	wds:Q56384025-2CEE8998-CBBF-4154-B26E-A7F4B6FEAAA5
sex or gender	wds:Q56384025-025EE225-6C00-4108-9476-99068543BE28
on focus list of Wikimedia project	wds:Q56384025-B130CE5C-FE41-460D-84C9-A3A25C5FCB80
occupation	researcher
sex or gender	female organism
on focus list of Wikimedia project	WikiProject COVID-19
ORCID iD	wds:Q56384025-1D480967-B407-46A3-A584-1BD146F7894E
ORCID iD	https://orcid.org/0000-0001-5246-928X
ORCID iD	0000-0001-5246-928X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q56384025
is author of	Etravirine for the treatment of HIV infection. Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients. Sex differences in nevirapine disposition in HIV-infected patients Nelfinavir suspension obtained from nelfinavir tablets has equivalent pharmacokinetic profile. Clinical pharmacokinetics of nelfinavir combined with efavirenz and stavudine during rescue treatment of heavily pretreated HIV-infected patients Impact of a treatment including tenofovir plus didanosine on the selection of the 65R mutation in highly drug-experienced HIV-infected patients Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting Hydroxyurea and didanosine long-term treatment prevents HIV breakthrough and normalizes immune parameters High plasma levels of nelfinavir and efavirenz in two HIV-positive patients with hepatic disease Structured treatment interruptions to control HIV-1 infection Hepatitis C infection on immune recovery in HIV-positive patients on successful HAART: the role of genotype 3. Modulation of human immunodeficiency virus (HIV)-specific immune response by using efavirenz, nelfinavir, and stavudine in a rescue therapy regimen for HIV-infected, drug-experienced patients Changes in darunavir/r resistance score after previous failure to tipranavir/r in HIV-1-infected multidrug-resistant patients High-performance liquid chromatography method for analyzing the antiretroviral agent efavirenz in human plasma Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease. Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy Pharmacokinetics of amprenavir given once or twice a day when combined with atazanavir in heavily pre-treated HIV-positive patients Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia Control of HIV during a structured treatment interruption in chronically infected individuals with vigorous T cell responses. Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol A Prospective Multicentre Study of the Epidemiology and Outcomes of Bloodstream Infection in Cirrhotic Patients Tuberculosis-induced haemophagocytic syndrome in a patient on haemodialysis treated with anti-thymocyte globulin Steady-state pharmacokinetics of atazanavir given alone or in combination with saquinavir hard-gel capsules or amprenavir in HIV-1-infected patients Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individuals. Post-exposure rate of tuberculosis infection among health care workers measured with tuberculin skin test conversion after unprotected exposure to patients with pulmonary tuberculosis: 6-year experience in an Italian teaching hospital Multiple relapses of human cytomegalovirus retinitis during HAART in an AIDS patient with reconstitution of CD4+ T cell count in the absence of HCMV-specific CD4+ T cell response Epidemiology of Mycobacterium tuberculosis infection in Pavia province, Lombardy, Northern Italy, 1998-2013. Higher plasma lopinavir concentrations are associated with a moderate rise in cholestasis markers in HIV-infected patients. Amprenavir and ritonavir plasma concentrations in HIV-infected patients treated with fosamprenavir/ritonavir with various degrees of liver impairment. Extended Infusion of β-Lactams for Bloodstream Infection in Patients With Liver Cirrhosis: An Observational Multicenter Study Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project) Colitis in an elderly immunocompetent patient Early and late effects of highly active antiretroviral therapy: a 2 year follow-up of antiviral-treated and antiviral-naive chronically HIV-infected patients Evaluation of a model to improve collection of blood cultures in patients with sepsis in the emergency room. Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients Redistribution of human immunodeficiency virus type 1 variants resistant to protease inhibitors after a protease inhibitor-sparing regimen. Haemostatic Activation in HIV Infected Patients Treated with Different Antiretroviral Regimens Outbreak of measles genotype H1 in Northern Italy originated from a case imported from Southeast Asia, 2017 Differences in implementation of HIV/AIDS clinical research in developed versus developing world: an evidence-based review on protease inhibitor use among women and minorities. The role of qSOFA compared to other prognostic scores in septic patients upon admission to the emergency department Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: a pilot randomised trial Aetiology and outcome of pneumoniae in HIV-positive patients in the antiretroviral era. Infective endocarditis in patients with hepatic diseases. Prosthetic Joint Infection from Carbapenemase-Resistant Successfully Treated with Ceftazidime-Avibactam Mitral Valve Infective Endocarditis due to Streptococcus pyogenes: A Case Report. Migrations do not modify Mycobacterium tuberculosis resistance rates: a 20-year retrospective study Response to antiretroviral treatment after failure of NNRTI plus NRTIs-based therapy. Data from the ARCA collaborative group.
is author of	wds:Q44699305-7B0F9321-CAF6-4E18-8576-560DFF0CDF86 wds:Q73068327-30997A57-39F6-495B-B578-71F269F6A1DB wds:Q95939263-084D3FA4-ED7B-40BA-A4B2-6BC72DFFE9D0 wds:Q40510520-5E736A82-A8D5-4602-A763-8DDFA4CA9636 wds:Q95391716-1EF13242-D225-4922-B31A-E5504F722029

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software